UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 346

Sortiert nach

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1379-1389

2020

Link zum Volltext

Verfügbarkeit prüfen

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

PLoS pathogens, 2017-05, Vol.13 (5), p.e1006373-e1006373

2017

Link zum Volltext

Verfügbarkeit prüfen

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Journal of the International AIDS Society, 2017-07, Vol.20 (1), p.22146-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study

PloS one, 2011-03, Vol.6 (3), p.e17781-e17781

2011

Link zum Volltext

Verfügbarkeit prüfen

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

The Journal of infectious diseases, 2022-05, Vol.225 (10), p.1688-1693

2022

Link zum Volltext

Verfügbarkeit prüfen

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

Clinical infectious diseases, 2021-07, Vol.73 (2), p.e485-e493

2021

Link zum Volltext

Verfügbarkeit prüfen

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2429-2438

2012

Link zum Volltext

Verfügbarkeit prüfen

Late HIV diagnosis: Where we stand and the way forward

HIV medicine, 2022-12, Vol.23 (11), p.1115-1117

2022

Link zum Volltext

Verfügbarkeit prüfen

Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era

Clinical infectious diseases, 2021-09, Vol.73 (5), p.e1222-e1227

2021

Link zum Volltext

Verfügbarkeit prüfen

The way forward in HCV treatment - finding the right path

Nature reviews. Drug discovery, 2007-12, Vol.6 (12), p.991-1000

2007

Link zum Volltext

Verfügbarkeit prüfen

HIV-related stigma within communities of gay men: a literature review

AIDS care, 2012-04, Vol.24 (4), p.405-412

2012

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

The Lancet (British edition), 2015-03, Vol.385 (9973), p.1098-1106

2015

Link zum Volltext

Verfügbarkeit prüfen

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

The Lancet infectious diseases, 2012-02, Vol.12 (2), p.111-118

2012

Link zum Volltext

Verfügbarkeit prüfen

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

PloS one, 2022-05, Vol.17 (5), p.e0267853-e0267853

2022

Link zum Volltext

Verfügbarkeit prüfen

Late presentation of chronic viral hepatitis for medical care: a consensus definition

BMC medicine, 2017-05, Vol.15 (1), p.92-92, Article 92

2017

Link zum Volltext

Verfügbarkeit prüfen

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

The New England journal of medicine, 2004-07, Vol.351 (5), p.438-450

2004

Link zum Volltext

Verfügbarkeit prüfen

Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men

PloS one, 2019-01, Vol.14 (1), p.e0210179-e0210179

2019

Link zum Volltext

Verfügbarkeit prüfen

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

EClinicalMedicine, 2021-10, Vol.40, p.101116-101116, Article 101116

2021

Link zum Volltext

Verfügbarkeit prüfen

Too many people with viral hepatitis are diagnosed late - with dire consequences

Nature reviews. Gastroenterology & hepatology, 2019-08, Vol.16 (8), p.451-452

2019

Link zum Volltext

Verfügbarkeit prüfen

Living donor liver transplant from an HIV-positive individual to an HIV-negative individual: could this become a new reality?

AIDS (London), 2018-10, Vol.32 (16), p.2423-2424

2018

Link zum Volltext

Verfügbarkeit prüfen

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

PloS one, 2019-01, Vol.14 (1), p.e0210965-e0210965

2019

Link zum Volltext

Verfügbarkeit prüfen

Implementation of EACS vaccination recommendations among people living with HIV

Infection, 2022-12, Vol.50 (6), p.1491-1497

2022

Link zum Volltext

Verfügbarkeit prüfen

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

Clinical infectious diseases, 2016-09, Vol.63 (6), p.821-829

2016

Link zum Volltext

Verfügbarkeit prüfen

Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2005-09, Vol.192 (6), p.992-1002

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(326)
Mit Volltextzugriff
(306)

Publikationsform

Sprache

Englisch
(335)
Japanisch
(18)
Deutsch
(10)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(265)
Life Sciences & Biomedicine
(256)
Humans
(246)
Infectious Diseases
(195)
Male
(149)
Hiv
(145)
Adult
(130)
Female
(123)
Human Immunodeficiency Virus
(113)
Middle Aged
(111)
Hiv Infections - Drug Therapy
(109)
Biological And Medical Sciences
(101)
Medical Sciences
(99)
Immunology
(94)
Hiv Infections - Complications
(86)
Viral Diseases
(82)
Human Viral Diseases
(78)
Virology
(76)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(63)
Hepatitis C
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Late HIV diagnosis: Where we stand and the way forward

Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era

The way forward in HCV treatment - finding the right path

HIV-related stigma within communities of gay men: a literature review

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

Late presentation of chronic viral hepatitis for medical care: a consensus definition

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

Too many people with viral hepatitis are diagnosed late - with dire consequences

Living donor liver transplant from an HIV-positive individual to an HIV-negative individual: could this become a new reality?

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial

Implementation of EACS vaccination recommendations among people living with HIV

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy

Suchergebnisse filtern